(NASDAQ:ATYR), NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against aTyr Pharma, Inc. (“aTyr” or the “Company”) (NASDAQ: ATYR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to […]

(NYSE:BAX), NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to

(NASDAQ:MRX), NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Marex Group Plc (“Marex” or the “Company”) (NASDAQ: MRX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in MoonLake Immunotherapeutics of Class Action Lawsuit and Upcoming Deadlines – MLTX GlobeNewswire October 30, 2025 NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against MoonLake Immunotherapeutics (“Moonlake” or the “Company”) (NASDAQ:

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Marex Group Plc of Class Action Lawsuit and Upcoming Deadlines – MRX GlobeNewswire October 30, 2025 NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Marex Group Plc (“Marex” or the

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in aTyr Pharma, Inc. of Class Action Lawsuit and Upcoming Deadlines – ATYR GlobeNewswire October 30, 2025 NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against aTyr Pharma, Inc. (“aTyr” or the

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Baxter International, Inc. of Class Action Lawsuit and Upcoming Deadlines – BAX GlobeNewswire October 30, 2025 NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Baxter International, Inc. (“Baxter” or the

Fagen Friedman & Fulfrost, LLP (F3 Law), a leading education law firm dedicated to serving schools and educational institutions nationwide, and Kriha Boucek LLC (KB), a respected and growing Illinois-based law firm with deep roots in education law, announced today that KB will join F3 Law effective January 1, 2026. The combination will create one

Liminatus Pharma, Inc. (NASDAQ: LIMN) Signs MOU with Capital Trust Group for USD 30 Million Equity Investment via an earn-out mechanism and Future Strategic Cooperation GlobeNewswire October 30, 2025 LA PALMA, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) — Liminatus Pharma, Inc. (NASDAQ: LIMN), a clinical-stage immuno-oncology company developing next-generation CD47-blockade therapies, announced today that it

(NYSE:JHX), NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against James Hardie Industries plc (“James Hardie” or the “Company”) (NYSE: JHX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are